1. Home
  2. NATL vs MYGN Comparison

NATL vs MYGN Comparison

Compare NATL & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCR Atleos Corporation

NATL

NCR Atleos Corporation

HOLD

Current Price

$44.42

Market Cap

3.0B

Sector

N/A

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.77

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NATL
MYGN
Founded
2023
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
444.2M
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
NATL
MYGN
Price
$44.42
$4.77
Analyst Decision
Hold
Buy
Analyst Count
4
8
Target Price
$45.60
$7.64
AVG Volume (30 Days)
1.0M
1.5M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
73.98
N/A
EPS
2.14
N/A
Revenue
$4,354,000,000.00
$771,400,000.00
Revenue This Year
$6.13
$6.89
Revenue Next Year
$4.24
$5.35
P/E Ratio
$20.32
N/A
Revenue Growth
0.86
2.33
52 Week Low
$23.18
$3.76
52 Week High
$48.50
$8.59

Technical Indicators

Market Signals
Indicator
NATL
MYGN
Relative Strength Index (RSI) 57.28 50.55
Support Level $35.92 $4.23
Resistance Level $48.50 $5.69
Average True Range (ATR) 0.87 0.26
MACD -0.02 0.04
Stochastic Oscillator 90.61 70.25

Price Performance

Historical Comparison
NATL
MYGN

About NATL NCR Atleos Corporation

NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: